Strategies for preserving residual renal function in peritoneal dialysis patients
A Nongnuch, M Assanatham, K Panorchan… - Clinical kidney …, 2015 - academic.oup.com
Although there have been many advancements in the treatment of patients with chronic
kidney disease (CKD) over the last 50 years, in terms of reducing cardiovascular risk, mortality …
kidney disease (CKD) over the last 50 years, in terms of reducing cardiovascular risk, mortality …
[HTML][HTML] SARS-CoV-2-specific humoral and cell-mediated immune responses after immunization with inactivated COVID-19 vaccine in kidney transplant recipients …
…, S Thotsiri, S Upama, M Assanatham… - American Journal of …, 2022 - Elsevier
Immunogenicity following inactivated SARS-CoV-2 vaccination among solid organ
transplant recipients has not been assessed. Seventy-five patients (37 kidney transplant [KT] …
transplant recipients has not been assessed. Seventy-five patients (37 kidney transplant [KT] …
[HTML][HTML] Mineral metabolism and outcomes in chronic kidney disease stage 2–4 patients
K Chartsrisak, K Vipattawat, M Assanatham… - BMC nephrology, 2013 - Springer
Background Marked hyperphosphatemia, hyperparathyroidism and 25-hydroxyvitamin D
deficiency are associated with mortality in dialysis patients. Such data in chronic kidney …
deficiency are associated with mortality in dialysis patients. Such data in chronic kidney …
[HTML][HTML] Immunogenicity of ChAdOx1 nCoV-19 vaccine after a two-dose inactivated SARS-CoV-2 vaccination of dialysis patients and kidney transplant recipients
…, S Kiertiburanakul, K Malathum, M Assanatham… - Scientific Reports, 2022 - nature.com
Vaccination with inactivated SARS-CoV-2 virus produces suboptimal immune responses
among kidney transplant (KT), peritoneal dialyzed (PD), and hemodialyzed (HD) patients. …
among kidney transplant (KT), peritoneal dialyzed (PD), and hemodialyzed (HD) patients. …
[HTML][HTML] Urine epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as biomarkers for interstitial fibrosis and tubular atrophy in primary …
…, A Nongnuch, M Assanatham… - Kidney and Blood …, 2016 - karger.com
Background/Aims: The degree of tubular atrophy and interstitial fibrosis (IFTA) is an important
prognostic factor in glomerulonephritis. Imbalance between pro-inflammatory cytokines …
prognostic factor in glomerulonephritis. Imbalance between pro-inflammatory cytokines …
[HTML][HTML] Economic evaluation of peritoneal dialysis and hemodialysis in Thai population with End-stage Kidney Disease
M Assanatham, O Pattanaprateep… - BMC Health Services …, 2022 - Springer
Background This study aimed to conduct a cost-utility analysis of the “Peritoneal Dialysis (PD)-First”
policy in 2008 under a universal health coverage scheme and hemodialysis (HD) in …
policy in 2008 under a universal health coverage scheme and hemodialysis (HD) in …
[HTML][HTML] Predicting treatment response and clinicopathological findings in lupus nephritis with urine epidermal growth factor, monocyte chemoattractant protein-1 or …
…, S Kantachuvesiri, A Nongnuch, M Assanatham… - PLoS …, 2022 - journals.plos.org
Introduction There is a need for sensitive and specific biomarkers to predict kidney damage
and therapeutic response in lupus nephritis (LN). Monocyte chemoattractant protein-1 (MCP-…
and therapeutic response in lupus nephritis (LN). Monocyte chemoattractant protein-1 (MCP-…
[HTML][HTML] An additional dose of viral vector COVID-19 vaccine and mRNA COVID-19 vaccine in kidney transplant recipients: A randomized controlled trial (CVIM 4 study …
…, S Boongird, A Nongnuch, M Assanatham… - American Journal of …, 2022 - Elsevier
Immunogenicity following an additional dose of Coronavirus disease 2019 (COVID-19) vaccine
was investigated in an extended primary series among kidney transplant (KT) recipients. …
was investigated in an extended primary series among kidney transplant (KT) recipients. …
[HTML][HTML] Durability of humoral and cellular immunity after an extended primary series with heterologous inactivated SARS-Cov-2 prime-boost and Chadox1 NCOV-19 …
…, P Chuengsaman, A Nongnuch, M Assanatham… - Vaccines, 2022 - mdpi.com
The durability of a three-dose extended primary series of COVID-19 vaccine in dialysis
patients remains unknown. Here, we assessed dynamic changes in SARS-CoV-2-specific …
patients remains unknown. Here, we assessed dynamic changes in SARS-CoV-2-specific …
Anti–SARS-CoV-2 spike protein S1 receptor-binding domain antibody after vaccination with inactivated whole-virus SARS-CoV-2 in end-stage kidney disease patients …
…, R Kitpermkiat, M Assanatham… - Kidney …, 2021 - kidney-international.org
We feel deep gratitude to the patients who donated their blood samples and clinical data for
this project. We would like to acknowledge the excellent technical assistance as well as the …
this project. We would like to acknowledge the excellent technical assistance as well as the …